{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:52:03Z","timestamp":1791021123027,"version":"4.1.0"},"reference-count":33,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Intern Med"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Nonalcoholic fatty liver disease (NAFLD) is considered a multisystem disease, as it is bidirectionally linked to other cardiometabolic disorders, such as type 2 diabetes (T2D). However, the long\u2010term risk for microvascular outcomes in NAFLD is unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using the outpatient part of the nationwide Swedish Patient Register in the time period between 01\/01\/2002 and 12\/31\/2019, we identified all individuals with a first NAFLD diagnosis (<jats:italic>N<\/jats:italic>\u00a0=\u00a06785) and matched these (age, sex, and municipality) with up to 10 reference individuals from the general population (<jats:italic>N<\/jats:italic>\u00a0=\u00a061,136). Using population\u2010based registers, we ascertained the development of microvascular diseases. The primary outcome was defined as a composite outcome of any diagnosis representative of microvascular disease (chronic kidney disease, retinopathy, or neuropathy). As secondary outcomes, we separately examined the risk of each specific microvascular outcome. Hazard ratios (aHR, adjusted for cirrhosis and time\u2010varying T2D, hypertension, and hyperlipidemia) for the outcomes were calculated by Cox proportional\u2010hazards models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Median follow\u2010up was 5.7 years. The incidence rate of microvascular diseases was &gt;twofold higher in patients with NAFLD (10.8 per 1000 person\u2010years [95% confidence interval (CI)\u00a0=\u00a09.9\u201311.8]) versus reference individuals (4.7 per 1000 person\u2010years [95%CI\u00a0=\u00a04.5\u20134.9]). NAFLD was independently and positively associated with the development of microvascular diseases compared to non\u2010NAFLD subjects (aHR\u00a0=\u00a01.45 [95%CI\u00a0=\u00a01.28\u20131.63]). When stratifying the analysis by follow\u2010up time, sex, or age categories, results remain virtually unchanged.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>NAFLD is positively and independently associated with the development of microvascular diseases. The risk for development of microvascular diseases should be taken into account in the personalized risk assessment of individuals with NAFLD.<\/jats:p><\/jats:sec>","DOI":"10.1111\/joim.13673","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T05:03:40Z","timestamp":1685595820000},"page":"216-227","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Increased risk for microvascular outcomes in NAFLD\u2014A nationwide, population\u2010based cohort study"],"prefix":"10.1111","volume":"294","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1683-9276","authenticated-orcid":false,"given":"Thomas","family":"Ebert","sequence":"first","affiliation":[{"name":"Department of Clinical Science, Intervention and Technology, Division of Renal Medicine Karolinska Institutet Stockholm Sweden"},{"name":"Medical Department III \u2010 Endocrinology, Nephrology, Rheumatology University of Leipzig Medical Center Leipzig Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linnea","family":"Widman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Huddinge Karolinska Institutet Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8785-4820","authenticated-orcid":false,"given":"Peter","family":"Stenvinkel","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, Intervention and Technology, Division of Renal Medicine Karolinska Institutet Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8474-1759","authenticated-orcid":false,"given":"Hannes","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Medicine, Huddinge Karolinska Institutet Stockholm Sweden"},{"name":"Department of Upper GI Diseases Karolinska University Hospital Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00165-0"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13343"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322786"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31845"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00448-y"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.173"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007101155"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154433"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31726"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2017.11.003"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1720-1"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0897-4"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12964"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.08.024"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2022.2051202"},{"key":"e_1_2_10_18_1","first-page":"41","volume-title":"Kvalitet och inneh\u00e5ll i patientregistret Utskrivningar fr\u00e5n slutenv\u00e5rden 1964\u20132007 och bes\u00f6k i specialiserad \u00f6ppenv\u00e5rd (exklusive prim\u00e4rv\u00e5rdsbes\u00f6k) 1997\u20132007","author":"Forsberg L","year":"2009"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-016-0117-y"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa575"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.06.021"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-450"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-017-0316-1"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/02841860802247664"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1294"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1999.10474144"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00020-0"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00308-3"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.02.004"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2019.03.009"},{"key":"e_1_2_10_31_1","article-title":"Association of metabolic dysfunction\u2010associated fatty liver disease with kidney disease","volume":"10","author":"Wang T\u2010Y","year":"2022","journal-title":"Nat Rev Nephrol."},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11040968"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05362-7"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1103-x"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/joim.13673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T04:27:24Z","timestamp":1692332844000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/joim.13673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1111\/joim.13673"],"URL":"https:\/\/doi.org\/10.1111\/joim.13673","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,5]]},"assertion":[{"value":"2023-06-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}